glp-1 in type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness Glucagon-like peptide-1 - Wikipedia

This scientific backing gave me a lot of confidence in trying them

The SELECT trial, as noted earlier, went a step further it tested Wegovy in overweight/obese individuals with cardiovascular disease (but without diabetes) and found a 20% reduction in heart attacks, stroke, or CV death ( [67] )

The significant increase in risk is driven primarily by enteric hyperoxaluria, reduced urinary citrate, and lower urine volume. As clinicians continue to monitor outcomes, Wood emphasized that hydration remains one of the simplest and most effective ways for GLP1 users, especially those with a history of stones, to support kidney health.

Ozempic (multi-dose pen) contains disodium phosphate dihydrate and phenol as a preservative, while Wegovy (single-dose pen) has a different formulation